A veteran analytical team elevated Palantir’s 12-month price target to $230 following exceptionally strong first-quarter results. The firm cited accelerated government contract wins and higher recurring subscription revenue as the primary catalysts for the revision.

Despite the earnings beat and bullish outlook, Palantir shares have held near $137.80, underperforming both major technology benchmarks and high-yield dividend stocks. Investors point to profit-taking and valuation concerns as reasons for the lag, setting the stage for potential entry points.